ReviewPathogens (Basel, Switzerland)2026
Understanding Basic Concepts of Viral Quasispecies: From Evolutionary Dynamics to Clinical Relevance.
Review in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This review examines the viral quasispecies concept and its implications for understanding viral evolution, pathogenesis, and the development of effective antiviral therapies. Quasispecies are dynamic populations of closely related but genetically distinct viral genomes, which evolve under mutation and Darwinian selection. Notably, minority variants, often dismissed as "genetic noise", may harbor significant biological differences-such as drug resistance-and become dominant under changing selective pressures. Next-generation sequencing (NGS) has become an indispensable tool for characterizing genetic diversity within quasispecies, enabling detection and quantitative analysis of minority variants often missed by conventional Sanger sequencing, as well as the calculation of diversity indices. We highlight two NGS-based studies of hepatitis B virus quasispecies as illustrative examples of the relevance of minority variants in antiviral resistance and clinical outcomes. These studies also exemplify transcomplementation, whereby defective viral genomes can be replicated and packaged through functional proteins provided by co-infecting variants. Finally, we discuss how the quasispecies concept may extend beyond viruses, with parallels in biological systems such as the adaptive immune system and tumor cell populations. Recognizing quasispecies as dynamic evolving populations rather than static entities is crucial for developing successful strategies to address infectious diseases and other complex biological challenges.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.